cAMP-induced degradation of cyclin D3 through association with GSK-3β
Author(s) -
Soheil Naderi,
Kristine B. Gützkow,
Hege U. Låhne,
Siri Lefdal,
W.J. Ryves,
Adrian J. Harwood,
Heidi Kiil Blomhoff
Publication year - 2004
Publication title -
journal of cell science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.384
H-Index - 278
eISSN - 1477-9137
pISSN - 0021-9533
DOI - 10.1242/jcs.01210
Subject(s) - biology , cyclin dependent kinase complex , cyclin d , cyclin a , gsk 3 , cyclin , cyclin d1 , microbiology and biotechnology , cyclin a2 , phosphorylation , cyclin b , cyclin d3 , cyclin e , biochemistry , cell cycle , protein kinase a , cyclin dependent kinase 2 , cell
In this study we report a new mechanism whereby cyclic AMP (cAMP) regulates the cell-cycle machinery. We demonstrate that elevation of intracellular levels of cAMP promotes degradation of cyclin D3 in proteasomes, and that this occurs via glycogen synthase kinase-3beta (GSK-3beta)-mediated phosphorylation of cyclin D3 at Thr-283. Elevation of cAMP did not change the subcellular distribution of either cyclin D3 or GSK-3beta. However, cAMP promoted the interaction between cyclin D3 and GSK-3beta both in vitro and in vivo, indicating that GSK-3beta-mediated phosphorylation of cyclin D3 might require the association between the two proteins. These results demonstrate how cAMP enhances degradation of cyclin D3. Furthermore, we provide evidence for a novel mechanism by which GSK-3beta might phosphorylate unprimed substrates in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom